| Literature DB >> 10658169 |
Abstract
The metabolic myopathies are distinguished by extensive clinical and genetic heterogeneity within and between individual disorders. There are a number of explanations for the variability observed that go beyond single gene mutations or degrees of heteroplasmy in the case of mitochondrial DNA mutations. Some of the contributing factors include protein subunit interactions, tissue-specificity, modifying genetic factors, and environmental triggers. Advances in the molecular analysis of metabolic myopathies during the last decade have not only improved the diagnosis of individual disorders but also helped to characterize the contributing factors that make these disorders so complex.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10658169 DOI: 10.1016/s0733-8619(05)70179-1
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806